Abstract
Successful experimental models of intracerebral cell transplantation to enhance neurological recovery from stroke have prompted the pursuit of early phase clinical trials. Published results of three completed studies report that intracerebral delivery of cell therapy is safe and feasible; one study of fetal porcine transplant was stopped prior to full completion due to adverse events. Though early phase clinical trials are primarily for safety and tolerability, all published studies included some measures of neurologic deficit and attempted to identify functional improvement on follow-up. Many individual patients demonstrated objective functional improvement; however, due to small sample size, any conclusions regarding the beneficial nature of intracerebral cell therapy must be reserved until the completion of later phase trials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC et al (1984) Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line tera-2. Differentiation in vivo and in vitro. Lab Invest 50:147–162
Bang OY, Lee JS, Lee PH, Lee G (2005) Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57:874–882
Bliss T, Guzman R, Daadi M, Steinberg GK (2007) Cell transplantation therapy for stroke. Stroke 38:817–826
Borlongan CV, Sanberg PR (1995) Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism. J Neurosci 15:5372–5378
Borlongan CV, Koutouzis TK, Jorden JR, Martinez R, Rodriguez AI, Poulos SG et al (1997) Neural transplantation as an experimental treatment modality for cerebral ischemia. Neurosci Biobehav Rev 21:79–90
Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR (1998) Transplantation of cryopreserved human embryonal carcinoma-derived neurons (nt2n cells) promotes functional recovery in ischemic rats. Exp Neurol 149:310–321
Chen J, Li Y, Wang L, Lu M, Zhang X, Chopp M (2001a) Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 189:49–57
Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE et al (2001b) Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32:2682–2688
Chopp M, Li Y (2002) Treatment of neural injury with marrow stromal cells. Lancet Neurol 1:92–100
Coyne TM, Marcus AJ, Woodbury D, Black IB (2006) Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells 24:2483–2492
Deacon TW, Pakzaban P, Burns LH, Dinsmore J, Isacson O (1994) Cytoarchitectonic development, axon-glia relationships, and long distance axon growth of porcine striatal xenografts in rats. Exp Neurol 130:151–167
Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N, Itokazu Y et al (2004) Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 113:1701–1710
Dinsmore J, Martin J, Siegan J, Morrison J, Lindberg C, Ratliff J et al (2002) CNS grafts for treatment of neurologic disorders. In: Atala A, Lanza R (eds) Methods of tissue engineering. Academic, San Diego, pp 1127–1134
England TJ, Abaei M, Auer DP, Lowe J, Jones DR, Sare G et al (2012) Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial. Stroke 43:405–411
Guzman R, Choi R, Gera A, De Los Angeles A, Andres RH, Steinberg GK, Guzman R, Choi R, Gera A, De Los Angeles A, Andres RH, Steinberg GK (2008) Intravascular cell replacement therapy for stroke. Neurosurg Focus 24:E15
Hernandez P, Cortina L, Artaza H, Pol N, Lam RM, Dorticos E et al (2007) Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and ficoll density gradient centrifugation. Atherosclerosis 194:e52–e56
Hicks AU, Lappalainen RS, Narkilahti S, Suuronen R, Corbett D, Sivenius J et al (2009) Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Eur J Neurosci 29:562–574
Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R et al (2011) Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134:1790–1807
Isacson O, Deacon TW, Pakzaban P, Galpern WR, Dinsmore J, Burns LH (1995) Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat Med 1:1189–1194
Jin K, Sun Y, Xie L, Mao XO, Childs J, Peel A et al (2005) Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat. Neurobiol Dis 18:366–374
Johansson BB, Grabowski M (1994) Functional recovery after brain infarction: plasticity and neural transplantation. Brain Pathol 4:85–95
Kalladka D, Muir KW (2011) Stem cell therapy in stroke: designing clinical trials. Neurochem Int 59:367–370
Kleppner SR, Robinson KA, Trojanowski JQ, Lee VM (1995) Transplanted human neurons derived from a teratocarcinoma cell line (ntera-2) mature, integrate, and survive for over 1 year in the nude mouse brain. J Comp Neurol 357:618–632
Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J et al (2000) Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55:565–569
Kondziolka D, Steinberg GK, Cullen SB, McGrogan M (2004) Evaluation of surgical techniques for neuronal cell transplantation used in patients with stroke. Cell Transplant 13:749–754
Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J et al (2005) Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 103:38–45
Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY (2010) A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28:1099–1106
Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, Strazzer S et al (2009) Stem cell therapy in stroke. Cell Mol Life Sci 66:757–772
Luo Y (2011) Cell-based therapy for stroke. J Neural Transm 118:61–74
Meltzer CC, Kondziolka D, Villemagne VL, Wechsler L, Goldstein S, Thulborn KR et al (2001) Serial [18f] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke. Neurosurgery 49:586–591; discussion 591–592
Pakzaban P, Deacon TW, Burns LH, Isacson O (1993) Increased proportion of acetylcholinesterase-rich zones and improved morphological integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence. Exp Brain Res 97:13–22
Pakzaban P, Deacon TW, Burns LH, Dinsmore J, Isacson O (1995) A novel mode of immunoprotection of neural xenotransplants: masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system. Neuroscience 65:983–996
Pleasure SJ, Lee VM (1993) Ntera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J Neurosci Res 35:585–602
Saporta S, Borlongan CV, Sanberg PR (1999) Neural transplantation of human neuroteratocarcinoma (hnt) neurons into ischemic rats. A quantitative dose–response analysis of cell survival and behavioral recovery. Neuroscience 91:519–525
Savitz SI, Dinsmore JH, Wechsler LR, Rosenbaum DM, Caplan LR (2004) Cell therapy for stroke. Neurotherapeutics 1:406–414
Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR (2005) Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc Dis 20:101–107
Savitz SI, Chopp M, Deans R, Carmichael ST, Phinney D, Wechsler L (2011a) Stem cell therapy as an emerging paradigm for stroke (steps) ii. Stroke 42:825–829
Savitz SI, Misra V, Kasam M, Juneja H, Cox CS Jr, Alderman S et al (2011b) Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol 70:59–69
Shen LH, Li Y, Chen J, Zacharek A, Gao Q, Kapke A et al (2007) Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 27:6–13
Shyu WC, Lee YJ, Liu DD, Lin SZ, Li H (2006) Homing genes, cell therapy and stroke. Front Biosci 11:899–907
Stilley CS, Ryan CM, Kondziolka D, Bender A, DeCesare S, Wechsler L (2004) Changes in cognitive function after neuronal cell transplantation for basal ganglia stroke. Neurology 63:1320–1322
Stroemer P, Hope A, Patel S, Pollock K, Sinden J (2008) Development of a human neural stem cell line for use in recovery from disability after stroke. Front Biosci 13:2290–2292
Suárez-Monteagudo C, Hernández-Ramírez P, Alvarez-González L, García-Maeso I, de la Cuétara-Bernal K, Castillo-Díaz L et al (2009) Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study. Restor Neurol Neurosci 27:151–161
Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H et al (2004) Administration of cd34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114:330–338
Tang Y, Yasuhara T, Hara K, Matsukawa N, Maki M, Yu G et al (2007) Transplantation of bone marrow-derived stem cells: a promising therapy for stroke. Cell Transplant 16:159–169
Thompson TP, Lunsford LD, Kondziolka D (1999) Restorative neurosurgery: opportunities for restoration of function in acquired, degenerative, and idiopathic neurological diseases. Neurosurgery 45:741–752
Trojanowski JQ, Mantione JR, Lee JH, Seid DP, You T, Inge LJ et al (1993) Neurons derived from a human teratocarcinoma cell line establish molecular and structural polarity following transplantation into the rodent brain. Exp Neurol 122:283–294
Trojanowski JQ, Kleppner SR, Hartley RS, Miyazono M, Fraser NW, Kesari S et al (1997) Transfectable and transplantable postmitotic human neurons: a potential “platform” for gene therapy of nervous system diseases. Exp Neurol 144:92–97
Yasuhara T, Matsukawa N, Hara K, Maki M, Ali MM, Yu SJ et al (2009) Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev 18:1501–1514
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this chapter
Cite this chapter
Kondziolka, D., Harrison, G., Wechsler, L. (2013). Clinical Trials: Intracerebral Cell Therapy in Stroke Patients. In: Jolkkonen, J., Walczak, P. (eds) Cell-Based Therapies in Stroke. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1175-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1175-8_11
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1174-1
Online ISBN: 978-3-7091-1175-8
eBook Packages: MedicineMedicine (R0)